大费城美中医药协会第十五届年会邀请函 Invitation To SAPA-GP 15th Annual Conference

各位亲朋好友,

 

我们诚挚邀请您出席大费城美中医药协会第15届年会。大费城美中医药协会成立于2002年, 协会旨在服务大费城地区蓬勃发展的制药专业领域。

 

大费城美中医药协会第十五届年会将于2017年6月23日至24日在美国宾夕法尼亚州普鲁士国王的喜来登酒店(地址: Sheraton Valley Forge Hotel, 480 N Gulph Road, King of Prussia, PA, 19406, USA) 举行。预计会议将吸引近1000名参会人员, 他们分别来自于大型制药公司(辉瑞,默克,葛兰素史克,强生,赛诺菲,百时美施贵宝,诺华,安进,梯瓦制药等),生物科技/新药研发合同外包服务机构,法律/咨询公司以及学术/研究机构。

 

大费城美中医药协会2017年度会议拥有众多专题和演讲嘉宾,年会涵盖特邀演讲,主场报告,VIP专场以及招聘会和研讨会。 会议的主题是“为患者而努力:建设国际合作新环境, 引领创新药物开发”。

 

年会亮点:
特邀演讲:

  1. I) 提供细胞和基因治疗:大药厂的整体方案
  2. II) 制药行业的政策与新趋势

 

主场报告:
I) 大数据和人工智能:加速实现转化治疗的新兴典范

  1. II) 创新药物:变革患者关怀

VIP专场(仅限邀请):

  1. I) CEO论坛:中国创新药物研发进展
  2. II) 美中公共私营合作制(PPP):生物药物开发区域,技术转让和政府事务

III) 美中CRO局势:基于全球战略联盟以塑造成功

  1. IV) 医药/保健全球交易论坛
  2. VI) SAPA-Hopkins创业论坛

 

招聘会和研讨会:
I) 标定明日之我-- 成功驱动力计划(与ASCEND合作举办,ASCEND是泛亚洲最大的致力于服务北美商务专业人士的非盈利性泛亚组织)
II) 监管法规与市场准入
III) 中国生物制药研发前景展望

  1. IV) 探索多变的监管法规环境
  2. V) 生物仿制药发展:战略与要求
  3. VI) 中国临床试验设计与监管科学的现状与未来导向

 

午餐会(全体参会人员,六月二十四日中午):

  • 靶向成功:生物科技企业家训练营
  • 成功退休的六个关键策略
  • 整合执行发展项目:通向卓越领导力
  • Hatch-Waxman诉讼策略

 

真诚期待您的参与!

此致

 

敬礼

 

吴振华  博士

大费城美中医药协会会长

电话: 1-617-633-2589
邮箱: [email protected]

 

注册链接:

https://www.eventbrite.com/e/us-china-biopharma-congress-2017-sapa-gp-15th-annual-conference-tickets-32095991976

在线大会议程

https://sapa-gp.org/sapagp/event-single-page/?event-id=8812

注册链接二维码:



We cordially invite you to attend the 15th Annual Conference of the Sino-American Pharmaceuticals Professional Association Greater Philadelphia (SAPA-GP). Founded in 2002, SAPA-GP serves the rapidly growing pharmaceutical and health care community in the Greater Philadelphia area. 

SAPA-GP’s 15th Annual Conference will be held at the Sheraton Valley Forge Hotel, 480 N Gulph Road, King of Prussia, PA, 19406, USAon June 23-24, 2017. The conference is expected to attract >1000 attendees from highly diverse backgrounds including big pharma (Pfizer, Merck, GSK, JNJ, Sanofi, BMS, Novartis, Amgen, Teva, etc.), biotech/CROs, law/consulting firms, as well as academic and research institutions.

 

SAPA-GP’s 2017 Annual Conference will have a wonderful lineup of topics and speakers, including Plenary and VIP Sessions as well as a Job Fair and Workshops. The theme of the conference is “Winning for Patients:  Building Global Pharmaceutical Ecosystems and Delivering Breakthrough Medicines.”.

Read more
Register now

Highlights of the program include:


Plenary Sessions:
I) Innovative Medicines: Transforming Patient Care
II) Big Data and Artificial Intelligence: An Emerging Paradigm to Accelerate the Delivery of Transformational Therapies

 

Parallel Sessions:

  1. US-China Public Private Partnership (PPP): Biopharma Development Zones, Technology Transfers and Government Affairs
  2. US-China Cross-border Mergers and Acquisitions: Navigating the US Legal Landscape for Success
  3. US-China CRO Landscape: Building Success with Global Strategic Alliances
  4. Executive Luncheon co-organized with Penn Wharton China Center: Keys to Managing a Successful Global Innovative Enterprise and Strategic Business Leadership
  5. Venture Investment and Business Development Showcase, Featuring Case Studies on in-Licensing, IP Laws, and Technology Showcase with Investors

Job Fair and Workshops:

  1. Leadership Development
  2. Regulatory and Market Access
  3. Navigating through the Changing Regulatory Environment
  4. Biostatistics and Clinical Design

 

Read more
Register now

June 23rd, 2017, Friday

12:00 PM - 1:15 PM  Check-in

1:15 PM - 1:30 PM  Welcome Remarks  

Featured Presentation

1:30 – 2:00 PM

Delivering Cell and Gene Therapy: One Big Pharma’s Approach

Joe Tarnowski

PhD, Senior Vice President, Cell and Gene Therapy Platforms, PTS, R&D, GlaxoSmithKline

Plenary Session I

Big Data and Artificial Intelligence: Emerging Paradigm to Accelerate Delivery of Transformational Therapies

Session Chairs: Yuchen Bai / Han Dai

2:15 PM - 2:45 PM  The Role of Small and Big Data in Drug Discovery        

Gunaretnam (Guna) Rajagopal, Global Head of Computational Sciences within Discovery Sciences, Johnson & Johnson

2:45 PM - 3:15 PM  AI for Healthcare: Challenges and Opportunities.           

Sean Zhou, Senior director, Head of computer aided detection and diagnosis, Siemens Healthineers

3:15 PM - 3:45 PM  Construction of Biomedical Big Data Platform in Shanghai Jiaotong University and the Children Hospital of Shanghai   

Gilbert Feng, Executive director of the Big Data Platform in Shanghai Jiaotong University-Yale University Joint Center for Biostatistics and senior consultant in the National Center for Blood Disease Translational Medicine at Shanghai

3:45 PM - 4:15 PM  Coffee Break          

VIP Session A

CEO Forum

Session Chairs: Sean Zhang/ Xue Liang

2:45 PM - 3:15 PM        

3:15 PM - 3:45 PM    

3:45 PM - 4:15 PM   Coffee Break          

4:15 PM - 5:00 PM   Panel Discussion

Workshop I

Position Yourself for the Future – Power Plan for Success

Co-organized with ASCEND, the largest non-profit Pan-Asian organization for business professionals in North America

Session Chairs: Haifeng Cui/Hao Sun

4:15 PM - 4:40 PM  Optimized Potential through Emotional Intelligence

Jen Grover, Ascend         

4:40 PM - 5:05 PM  One Person, but Many Faces of Leadership: Flexing your style as a leader

Sue Crimmin, VP Sample Management Tech, GlaxoSmithKline

5:05 PM - 5:30 PM

Carolyn Buser-Doepner, VP, Head of Discovery Partnerships with Academia (DPAc), GlaxoSmithKline

Job Fair

2:00 PM - 5:30 PM

VIP Session B

US-China Public Private Partnership (PPP) : Biopharma Development Zones, Technology transfer and Government Affairs

Session Chairs: Jim Fendrick/ David Cragin

2:15 PM - 2:45 PM

Lauren Swartz, Director, International Business Investment, Department of Commerce, City of Philadelphia

2:45 PM - 3:15 PM  Development of SOTIO Immunotherapy: A Czech-China Story

Vladimír Hrusa, MBA, CEO of Sotio

3:15 PM - 3:45 PM  Guanhao Incubator: Create A Professional and Open Start-up Platform

Ellen Zhang, MPA, EMBA, Founder, partner, CEO, GuanHao Life & Health Incubator Co., LTD

3:45 PM - 4:15 PM  Coffee Break          

4:15 PM - 5:00 PM  Panel Discussion      

John Xu, PhD, Senior Vice President of Strategic Alliance, AbPro

Jim Huang, PhD, CEO, Ascendia Pharma

VIP Session C

US-China CRO landscape: Building Success with Strategic Alliances

Featuring participants from US and China CROs and Industry executives

Session Chairs: Li Cui/ Weifeng Tang

2:15 PM - 2:45 PM  Connecting Science to Patients: Immuno-Oncology and Translational Oncology Platforms

Michelle Mack, PhD, Director of Scientific Engagement, Crown Bioscience

2:45 PM - 3:15 PM  CRO Landscape      

Henry Lu, VP of Biology, WuXi AppTec

3:15 PM - 3:45 PM  Clinical development outsourcing

Karen Chu, Pharma D,Corporate Vice President, Clinical Research Services,Parexel

3:45 PM - 4:15 PM   Coffee Break          

4:15 PM - 5:00 PM   Panel Discussion      
Russell Dahl, VP, GBD Sundia

Mingjiu Chen, PhD, CEO, BioSynergics Inc.

Gala Dinner

6:00 – 9:30 PM

新乡市平原示范区

    Pingyuan Demonstration zone of Xinxiang

June 24th, 2017, Saturday

8:15 AM - 8:55 AM  Check-in and Continental Breakfast

8:55 AM - 9:00 AM Welcome Remarks

Featured Presentation

9:00 AM - 9:30 AM  Policies and New Trend in Pharmaceutical Industry

Mingde Yu, President, Chinese Pharmaceutical Enterprises Association

Plenary Session II

Innovative Medicines: Transforming Patient Care

Session Chairs: Yongchao Su/ Hanghang Zhang

9:30 AM - 10:00 AM  Together to create a world without lung cancer      

Li Mao, M.D., Vice President and Head of the Johnson & Johnson China Lung Cancer Center

10:00 AM - 10:30 AM  Engineering the Environment of the Gut to Treat Inflammatory Bowel Disease       

Gary Wu, Ferdinand G. Weisbrod Professor in Gastroenterology, University of Pennsylvania, School of Medicine

10:30 AM - 10:45 AM   Coffee Break

Workshop II

Regulatory and Market Access

Regulatory Pathways for Bringing Innovative Products to Markets: Addressing the Needs of Patients and Payers


Session Chairs: Jim Wang/ Yufeng Li

10:45 AM - 11:10 AM  Orphan product development from first-in-human study to regulatory approval

Jim Wang, Head of Regulatory Affairs Strategy, Spark Therapeutics, Inc.

11:10 AM - 11:45 AM  Development of target product profile and product labeling

Paul Savidge, Senior Regulatory Counsel, Spark Therapeutics, Inc.

11:45 AM - 12:15 PM  Health outcome analysis for payer endorsement

Kim Gilchrist, Senior Director, Value Evidence & Outcomes, GlaxoSmithKline  

Workshop III

Perspectives of Biopharma R&D in China

Session chair: John Xu

10:45 AM - 11:15 AM  Kelun- Scientific Truth- Seeking, Ethics for Good

Jingyi Wang, President of the Research Institute, Kelun Pharmaceutical Co., Ltd

11:15 AM - 11:45 AM  Pharmaceutic R&D in China: Opportunities and Challenges and Keys to Managing a MNC R&D Center in China

Mingqiang Zhang, Vice President of R&D, Head of Amgen Asia R&D Center

11:45 AM - 12:15

 

2017-06-13T12:00:04+00:00